Lundbeck is a global pharmaceutical company highly committed to improving the quality of life for people living with brain diseases. For more than 70 years, Lundbeck has been at the forefront of neuroscience research, tirelessly dedicated to restoring brain health so every person can be their best. The company is engaged in the research, development, manufacturing, and sale of pharmaceuticals across the world. Products are targeted at disorders like depression, schizophrenia, Parkinson's disease, Alzheimer's disease, and migraine.
The headquarters houses corporate management, global research and development leadership, strategic planning, manufacturing, and administrative functions supporting Lundbeck's worldwide operations.
The Valby campus features modern research laboratories, manufacturing facilities, and office spaces designed to foster collaboration and innovation. It has undergone significant expansions and modernizations to support its role as a leading neuroscience research hub.
Lundbeck's HQ fosters a collaborative, science-driven, and patient-centric work culture. There is a strong emphasis on cross-functional teamwork and a commitment to ethical practices and sustainability.
The Valby headquarters is the historical home of Lundbeck and central to its identity, strategic direction, and global R&D efforts. It anchors its research, development, manufacturing, and commercial activities worldwide.
Lundbeck has a robust global presence, operating in more than 50 countries worldwide. Key functions supported globally include: extensive research and development (centered in Denmark with global collaborations), manufacturing (production sites in Denmark, France, and Italy), commercial operations (sales, marketing, market access), medical affairs, clinical development programs across numerous countries, and comprehensive corporate support functions. This widespread network ensures that Lundbeck can develop, produce, and deliver its specialized treatments for brain diseases to patients around the world.
Ottiliavej 9
Valby, Copenhagen
Region Hovedstaden
Denmark
Address: 6 Parkway North, Deerfield, IL 60015, USA
Focuses on bringing Lundbeck's therapies for brain diseases to patients in the United States, managing regulatory interactions with the FDA, and driving commercial growth in one of the world's largest pharmaceutical markets.
Address: Tour W, 102 Terrasse Boieldieu, 92800 Puteaux, La Défense, France
Ensures patient access to Lundbeck's brain health therapies within France, engages with French healthcare professionals and authorities, and contributes significantly to Lundbeck's European market presence and revenue.
Address: 1000 De La Gauchetière Street West, Suite 2620, Montréal, QC H3B 4W5, Canada
Dedicated to serving the needs of Canadian patients and healthcare professionals by providing innovative treatments for brain diseases and working within the Canadian healthcare system.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Lundbeck' leadership includes:
Lundbeck has been backed by several prominent investors over the years, including:
The most significant executive change in the past year (May 2023 - May 2024) was the transition in the President & CEO role, with Charl van Zyl taking over from Deborah Dunsire. Other top executive positions have seen stability following some appointments in early 2023.
Discover the tools Lundbeck uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Lundbeck primarily utilizes a 4-letter code format for employee email addresses. This code is typically derived from the employee's name (e.g., a combination of initials or specific letters from their first and last names). While this is the predominant internal format, specific regional offices or functional mailboxes might use other structures.
[4-letter_code]@lundbeck.com (e.g., JOSM@lundbeck.com for a John Smith, actual codes are specific internal derivations like TMMO@lundbeck.com)
Format
JURE@lundbeck.com
Example
80%
Success rate
Lundbeck Official Website • May 8, 2024
Lundbeck reported a 9% revenue increase in Q1 2024, reaching DKK 5,262 million. Growth was primarily driven by its four strategic brands: Rexulti/Rxulti, Brintellix/Trintellix, Abilify Maintena, and Vyepti. The company maintains its financial guidance for 2024....more
Lundbeck Official Website • February 5, 2024
Lundbeck and Conrig Pharma have entered into a research collaboration and exclusive licensing agreement to develop novel small molecule therapeutics for neuropathic pain. Lundbeck gains exclusive rights to develop and commercialize compounds from Conrig's CB1 receptor inverse agonist program....more
Lundbeck Official Website • October 2, 2023
Charl van Zyl officially started as President and CEO of H. Lundbeck A/S on October 1, 2023, succeeding Deborah Dunsire. Van Zyl brings extensive experience in the pharmaceutical industry, aiming to lead Lundbeck's continued focus on brain health innovation....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Lundbeck, are just a search away.